Multicenter Trial Management Unit Expands the Scope of Research at Yale
In the past, Yale investigators who led multicenter trials had to put together ad hoc study teams, relying on unconnected siloed services to carry out their research. At the end of these trials, these teams, which had compiled so much experience and knowledge, disbanded and their knowledge was lost. This system was inefficient and put Yale at a disadvantage when competing with other institutions for grants for multicenter studies.
Yale study: Social media boosts friendship quality in adolescents with autism spectrum disorder
A study by Yale Department of Psychiatry and Yale Child Study Center researchers found that adolescents with autism spectrum disorder (ASD) derive high friendship quality through their use of social media
Major autism study underway-Yale researchers leading the charge
A study that could transform the way autism is diagnosed, tracked and treated and the work is being done in New Haven. Yale researchers are leading the charge in the four year study – the largest autism study funded by National Institutes of Health.
Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Point-of-care Ultrasound's Global Potential
Yale School of Medicine (YSM) faculty, residents, and students are engaged with point-of-care ultrasound (POCUS) initiatives far from the Yale campus, such as in Chile, the Dominican Republic, Rwanda, and Uganda. With its portability and immediacy, POCUS is a powerful diagnostic tool, which also can enhance medical education, both on campus, and worldwide.
Minimizing blood vessel blockage
All cardiac procedures carry a risk of stroke because plaque or calcium buildup can break off in small pieces, ﬂoat up into the brain, and block narrow blood vessels. A highly specialized tool called an embolic protection device is currently used to prevent some of the released debris from reaching the brain.
Coleman Is Named to Federal Committee That Advises on Human Research Protections
Linda Coleman, JD, the director of the Yale Human Research Protection Program, which assists the university in meeting its ethical and regulatory obligations for the protection of human participants in research, has accepted an appointment to the Secretary’s Advisory Committee on Human Research Protection, which advises and makes recommendations to the Secretary of Health and Human Services.
Yale-developed Scorecard Promotes Better Clinical Trial Data Sharing
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing data, others could be more transparent to the benefit of science and the public, the researchers said.
Department of Neurology Receives Major Grant to Evaluate Blood Thinners and Stroke Prevention
Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.
Chen and Team Win Award from 2019 NIDA $100K SUD Startup Challenge
Kevin Chen, MD, fellow, National Clinical Scholars Program, and his team recently won an award as part of the 2019 NIDA $100K SUD Startup Challenge. Sponsored by the National Institute on Drug Abuse, the award is given to 10 winners for their startup projects to improve the well-being of those with substance use disorders.
Implementation Science: Putting Important Discoveries to Their Best Use
Scientific innovations are created every day, but how do we ensure that they are used efficiently and reach the people who need them most? David Chambers, DPhil, deputy director for implementation science in the Division of Cancer Control & Population Sciences at the National Cancer Institute, tackled that question during his June 25 grand rounds lecture titled “Advancing the Science of Implementation in Cancer Control: An NCI Perspective."
National Clinician Scholars Program enrolls new scholars, seeks next class
The National Clinician Scholars Program (NCSP) is an interprofessional fellowship program designed to prepare a select group of future clinician leaders through scholarship and action at the national, state, and local levels. On July 1, the NCSP at Yale welcomes eight new scholars to the program.
Yale Cancer Center Partners in Fight to Help Eliminate HPV-related Cancers
Yale Cancer Center joins the Association of American Cancer Institutes (AACI) and its partner organizations to endorse a Call to Action for our nation to work together toward the elimination of human papillomavirus (HPV)-related cancers.